Back to Authors

Weigand, Stephen D.

https://orcid.org/0000-0002-4541-9011

A5022452703 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 251

Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN

Neurology | July 14, 2011 | Volume: 77 | Issue: 4 | Pages: 393-398

10.1212/wnl.0b013e318227047f | PMID 21753165

DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment

Neurology | June 14, 2011 | Volume: 64 | Issue: 5 | Pages: 902-904

10.1212/01.wnl.0000153076.46126.e9 | PMID 15753434

Diffusion tensor imaging and cognitive function in older adults with no dementia

Neurology | May 19, 2011 | Volume: 77 | Issue: 1 | Pages: 26-34

10.1212/wnl.0b013e31822313dc | PMID 21593440

Neuromyelitis optica unique area postrema lesions

Neurology | March 3, 2011 | Volume: 76 | Issue: 14 | Pages: 1229-1237

10.1212/wnl.0b013e318214332c | PMID 21368286

Untreated Type 2 Diabetes and Its Complications Are Associated With Subcortical Infarctions

Diabetes Care | October 28, 2010 | Volume: 34 | Issue: 1 | Pages: 184-186

10.2337/dc10-0602 | PMID 20980413

OBJECTIVE To investigate the association of type 2 diabetes with subcortical infarctions. RESEARCH DESIGN AND METHODS We investigated this association in subjects with type 2 diabetes (case subjects; n = 93) and without type 2 diabetes (control subjects; n = 186), matched by age, sex, and years of education. Participants were a subset of the Mayo Clinic Study of Aging (median age 79 years) who had undergone magnetic resonance imaging. RESULTS The frequency of subcortical infarctions was 39% in case subjects and 29% in control subjects (odds ratio 1.59 [95% CI 0.91–2.75]). The association was stronger in case subjects without treatment (2.60 [1.11–6.08]) and in case subjects with diabetes-related complications (1.96 [1.02–3.74]) compared with control subjects. CONCLUSIONS These findings suggest that untreated type 2 diabetes and type 2 diabetes with complications are associated with subcortical infarctions.
Serial MRI and CSF biomarkers in normal aging, MCI, and AD

Neurology | July 12, 2010 | Volume: 75 | Issue: 2 | Pages: 143-151

10.1212/wnl.0b013e3181e7ca82 | PMID 20625167

O3‐06‐06: Regional patterns of 11C‐PiB uptake and cortical atrophy distinguishes dementia with Lewy bodies from Alzheimer's disease

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2010.05.432

P3‐180: Serial MRI and CSF biomarkers in normal aging, MCI and Alzheimer's disease

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_16 | Pages: No page available

10.1016/j.jalz.2010.05.1678

IC‐P‐111: Combining Scans Performed at Different Field Strengths in VBM Studies of Alzheimer's Disease

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2010.05.126

O2‐02‐02: Brain Aβ amyloid measures and MRI are complimentary predictors of progression from MCI to Alzheimer's disease

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2010.05.307